Methodological Divergence in Oncology HTA: Implications for International Harmonization and the Handling of Uncertainty

Nai-Chia Chen, Ash Bullement, Antal T. Zemplenyi, Cindy L. O’Bryant, Alex M. Kaizer, Kelly E. Anderson, Robert Brett McQueen

Open source

DOI
10.1007/s41669-026-00696-1
Published
2026-10-27
Container
PharmacoEconomics - Open
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s41669-026-00696-1,
  title = {Methodological Divergence in Oncology HTA: Implications for International Harmonization and the Handling of Uncertainty},
  author = {Nai-Chia Chen and Ash Bullement and Antal T. Zemplenyi and Cindy L. O’Bryant and Alex M. Kaizer and Kelly E. Anderson and Robert Brett McQueen},
  year = {2026},
  journal = {PharmacoEconomics - Open},
  doi = {10.1007/s41669-026-00696-1},
  url = {https://doi.org/10.1007/s41669-026-00696-1}
}

RIS

TY  - JOUR
TI  - Methodological Divergence in Oncology HTA: Implications for International Harmonization and the Handling of Uncertainty
AU  - Nai-Chia Chen
AU  - Ash Bullement
AU  - Antal T. Zemplenyi
AU  - Cindy L. O’Bryant
AU  - Alex M. Kaizer
AU  - Kelly E. Anderson
AU  - Robert Brett McQueen
PY  - 2026
JO  - PharmacoEconomics - Open
DO  - 10.1007/s41669-026-00696-1
UR  - https://doi.org/10.1007/s41669-026-00696-1
ER  - 

APA

Chen, N., Bullement, A., Zemplenyi, A. T., O’Bryant, C. L., Kaizer, A. M., Anderson, K. E., & McQueen, R. B. (2026). Methodological Divergence in Oncology HTA: Implications for International Harmonization and the Handling of Uncertainty. PharmacoEconomics - Open. https://doi.org/10.1007/s41669-026-00696-1

Source records